CD226 antibody (FITC)

Catalog No. ABIN7077042

Product Details anti-CD226 Antibody (FITC)

Target: CD226

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This CD226 antibody is conjugated to FITC

Application: Flow Cytometry (FACS)

Characteristics: The clone 11A8, a mouse monoclonal antibody, recognizes a ~65 kDa cell surface glycoprotein known as CD226.  It is a member of immunoglobulin superfamily containing two immunoglobulin-like variable domains. CD226 is widely expressed on peripheral blood T cells, NK cells, monocytes/macrophages, platelets and megakaryocytes and on a subset of B cells. It plays important role in the process of cytotoxic activities mediated by NK and T cells.

Purification: Purified

Purity: >95 %

Grade: GMP Grade

Immunogen: Human NK Cells

Clone: 11A8

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS pH 7.2, 0.2 % (w/v) BSA, 0.09 % (w/v) sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Target Details for CD226

Target: CD226

Alternative Name: CD226 (CD226 Products)

Synonyms: CD226 antibody, cd226 antibody, zgc:158817 antibody, BC051526 antibody, DNAM-1 antibody, DNAM1 antibody, Pta1 antibody, TLiSA1 antibody, PTA1 antibody, CD226 molecule antibody, CD226 antigen antibody, CD226 antibody, cd226 antibody, Cd226 antibody

Background: The clone 11A8, a mouse monoclonal antibody, recognizes a ~65 kDa cell surface glycoprotein known as CD226.  It is a member of immunoglobulin superfamily containing two immunoglobulin-like variable domains. CD226 is widely expressed on peripheral blood T cells, NK cells, monocytes/macrophages, platelets and megakaryocytes and on a subset of B cells. It plays important role in the process of cytotoxic activities mediated by NK and T cells.

Gene ID: 10666

UniProt: Q15762

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints